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Abstract
Background: The ability to wait and to weigh evidence is critical to behavioral regulation. These behaviors are known as 
waiting and reflection impulsivity. In Study 1, we examined the effects of methylphenidate, a dopamine and norepinephrine 
reuptake inhibitor, on waiting and reflection impulsivity in healthy young individuals. In study 2, we assessed the role of 
learning from feedback in disorders of addiction.
Methods: We used the recently developed 4-Choice Serial Reaction Time task and the Beads task. Twenty-eight 
healthy volunteers were tested twice in a randomized, double-blind, placebo-controlled cross-over trial with 20 mg 
methylphenidate. In the second study, we analyzed premature responses as a function of prior feedback in disorders of 
addiction.
Results: Study 1: Methylphenidate was associated with greater waiting impulsivity to a cue predicting reward along with 
faster responding to target onset without a generalized effect on reaction time or attention. Methylphenidate influenced 
reflection impulsivity based on baseline impulsivity. Study 2: More premature responses occurred after premature responses 
in stimulant-dependent subjects.
Conclusions: We show that methylphenidate has dissociable effects on waiting and reflection impulsivity. Chronic stimulant 
exposure impairs learning from prior premature responses, suggesting a failure to learn that premature responding is 
suboptimal. These findings provide a greater mechanistic understanding of waiting impulsivity.
Keywords: addiction, binge drinking, impulsivity, methylphenidate, premature responding, stimulant dependence
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Introduction
The capacity to wait prior to responding and to weigh evidence 
prior to a decision are critical elements of behavioral regula-
tion. These are subtypes of impulsivity known as waiting (Dalley 
et al., 2011) and reflection impulsivity (Kagan, 1966), respectively. 
Impulsivity is heterogeneous, with differing subtypes associ-
ated with distinct yet overlapping neural substrates.
Waiting impulsivity or premature responding describes 
anticipatory responses made prior to a cue predicting reward. 
It has been extensively investigated in rodent studies using the 
5-Choice Serial Reaction Time task (5-CSRT) (Robbins, 2002) and 
shown to be both a predictor of compulsive substance use as well 
as a consequence of drug exposure. The neurochemistry under-
lying waiting impulsivity in rodents implicates dopaminergic, 
noradrenergic, and serotonergic mechanisms (Bari and Robbins, 
2013). In rodents, methylphenidate (MPH) increases premature 
responding, an effect mediated by the beta-adrenergic receptor 
and D4 receptor (Milstein et al., 2010), and may be influenced by 
dose (Navarra et al., 2008) and baseline impulsivity (Tomlinson 
et al., 2014). MPH infusion into the rodent nucleus accumbens 
core also enhances premature responding (Economidou et al., 
2012). Translational versions of tasks assessing waiting impul-
sivity have recently been developed in humans. These include 
the 4-Choice Serial Reaction Time task (4-CSRT), which main-
tains fidelity to the rodent 5-CSRT (Voon, 2014; Voon et  al., 
2014), and the Sussex-5-CSRT task (Sanchez-Roige et al., 2014). 
Premature responding has been shown to be elevated in meth-
amphetamine, alcohol use disorders (AUDs), current smokers, 
and cannabis users with the 4-CSRT (Voon et al., 2014) and in 
binge drinkers (BDs) with the Sussex-5-CSRT task (Sanchez-
Roige et al., 2014). Potential mechanisms contributing to waiting 
impulsivity include the role of motivational processes, proactive 
or tonic inhibition, timing deficits, and sensitivity to negative 
feedback and delay (Voon, 2014). In rodent studies, impulsive 
responses followed more frequently after errors that resulted in 
reward omission with excitotoxic lesions of the nucleus accum-
bens core (Christakou et al., 2004).
Reflection impulsivity describes the accumulation of evi-
dence prior to decision (Kagan, 1966). In the Beads Task, partici-
pants view 2 jars with fixed probabilities of opposing ratios of 
red and blue beads. Beads are selected from 1 of the jars and 
shown to the participants. Participants must make a decision 
from which jar the beads are selected based on viewing the 
colored beads. The Beads task assesses reflection impulsivity in 
the probabilistic domain; participants are aware of the explicit 
probabilities of the alternate options with each piece of evi-
dence accumulated associated with an expected probability (or 
level of certainty) of being correct. Using this task, elevated prob-
abilistic reflection impulsivity has been observed in substance 
use disorders, pathological gamblers (Djamshidian et al., 2012), 
BDs (Banca et al., 2015), and patients with Parkinson’s disease 
with medication-induced behavioral addictions (Djamshidian 
et al., 2012). Reflection impulsivity tested using the Beads task 
is enhanced by dopamine receptor agonists though not by 
Levodopa (Djamshidian et  al., 2013) in studies of Parkinson’s 
disease.
In the first study, we focused on MPH, an indirect catecho-
lamine agonist that is commonly used as a cognitive enhancer 
in healthy individuals estimated at approximately 4% in col-
lege-age students in the United States (Bogle and Smith, 2009). 
MPH is also commonly used for the management of attention 
deficit hyperactivity disorder; this current study focuses on its 
use in young adult healthy volunteers. Acute MPH in healthy 
volunteers appears to have multiple influences on enhancing 
cognition, including enhancing set shifting and memory con-
solidation (Linssen et al., 2012), working memory and planning 
(Elliott et  al., 1997; Mehta et  al., 2000b), and improves motor 
response inhibition (Nandam et  al., 2011; Pauls et  al., 2012; 
Costa et al., 2013; Farr et al., 2014). However, some effects may 
be detrimental; MPH increases risk-taking behavior in healthy 
volunteers (Campbell-Meiklejohn et  al., 2012). This study thus 
addresses how MPH affects performance of 2 novel impulsivity 
tasks in healthy volunteers.
In the second study, we analyzed data from our previous stud-
ies using the 4-CSRT (Voon et al., 2014) in subjects with disorders 
linked with aberrant dopaminergic integrity in order to explore 
associations between more chronic dopaminergic changes and 
characteristics of premature responses. For example, abstinent 
methamphetamine dependent (Stim) have blunted striatal 
dopamine receptor availability (Volkow et al., 2001b) associated 
with impulsivity (Lee et  al., 2009), and individuals with AUDs 
have reduced ventral striatal dopamine transmission (Martinez 
et al., 2005) associated with alcohol craving (Heinz et al., 2004). 
Changes in dopamine transmission in obese subjects remains 
unclear with reported reductions in striatal D2 receptor binding 
that are associated with BMI (Wang et  al., 2001) as well as no 
difference in underlying Dopamine (DA) capacity (Davis et  al., 
2009) in obese with binge eating disorder (BED) but enhanced 
dopamine transmission at presentation of food stimulus in BED 
(Wang et al., 2011). We have also recently reported enhanced pre-
mature responding in BDs at elevated risk for the development of 
AUD (Morris et al., 2015). Here we extend an examination of the 
characteristic features of premature responses in these groups 
by specifically assessing the role of prior feedback. The negative 
reinforcement model suggests that negative reinforcers such 
as stress or anxiety may drive addiction processes (Koob, 2013). 
Whether this is relevant as an endophenotype or early or late in 
the addiction process remains to be established (Wise and Koob, 
2014). We hypothesize that Stim- and AUD-dependent individu-
als would have enhanced premature responses following nega-
tive feedback but not in healthy volunteers exposed to acute 
MPH or BDs, suggesting a role for development of negative rein-
forcement in the later stage of the addiction process.
Methods
In the first study, we recruited young healthy volunteers above the 
age of 18 years who were medication-free and without any history 
of psychiatric or medical disorders. Participants were tested twice 
in a double-blind, within-subject, randomized placebo-controlled 
study with a 1-week cross-over period. A total of 20 mg of short-act-
ing MPH was administered, following which participants sat qui-
etly or completed questionnaires. Participants were then tested at 
1 hour postadministration equivalent to peak dose. Subjects were 
tested on the National Adult Reading Test (Nelson, 1982) for Verbal 
IQ. Subjects completed the Beck Depression Inventory (Beck et al., 
1961), State and Trait Anxiety Inventory (Spielberger CD, 1983), and 
UPPS Impulsive Behaviour Scale (UPPS-P) (Whiteside and Lynam, 
2001) to assess for depression, anxiety, and impulsivity.
In the second study, we reanalyzed data from the 4-CSRT pre-
viously reported comparing Stim, AUD, obese subjects with and 
without BED (Voon et al., 2014), and BDs compared with healthy 
volunteers focusing on novel analyses to examine the influence 
of prior feedback on premature responding. The recruitment 
and diagnostic criteria and inclusion and exclusion criteria were 
previously reported (Voon et al., 2014). The study was approved 
by the University of Cambridge Research Ethics Committee.
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Choice Serial Reaction Time Task
The 4-CSRT task (Figure 1) was developed based on the rodent 
5-CSRT (Voon et al., 2014). Participants were seated in front of a 
10.1 LCD touch screen monitor. When 4 boxes appeared on the 
screen, the participant pressed and held down the space bar on 
the keyboard with their dominant index finger, indicating the “cue 
onset” time. After a specified period (cue-target interval), a green 
circle target appeared briefly and randomly in 1 of the 4 boxes. 
Participants released the space bar and touched the box in which 
the target appeared. Baseline blocks without monetary feedback 
were used to individualize monetary feedback amounts for sub-
sequent blocks based on the individual’s mean fastest reaction 
time (RT) and SD. The subsequent 4 Test blocks with monetary 
feedback were optimized to increase premature responding. This 
included variation of target duration, variability of the cue-target 
interval, and the presence of distractors. Accurate and timely 
responses were followed by individualized reward magnitude 
outcomes depending on the speed of responding. The task lasted 
20 minutes and was programmed in Visual Basic with Visual 
Studio 2005. See Voon et al. (2014) for further task details.
The premature responding task consisted of 2 Baseline 
blocks and 4 Test blocks. Baseline blocks (level 3); Test block 
feedback (level 3); Very fast accurate responses (level 4); fast 
accurate responses (level 4); slow accurate responses (level 4); 
no response (level 4); premature response or incorrect responses 
(level 4); Test blocks (level 3).
Baseline Blocks
The baseline blocks were used to calculate the individual’s mean 
RT and SD to individualize feedback according to the individ-
ual’s RT and encourage individuals to respond faster. The first 
baseline block occurred at the start of the trial with the mean RT 
used for test block 1. The second baseline block occurred at the 
end of test block 1 with the mean RT from both baseline blocks 
used for test blocks 2 to 4. The subjects were told to respond 
as quickly as possible during the baseline blocks and the words 
“Keep going” appeared on the screen as feedback.
Test block feedback: Each baseline block had 20 trials, with the 
final 10 trials used to calculate mean RT and SD to individualize 
feedback and incentivize faster responding in subsequent test 
blocks. On test blocks, subjects saw both feedback (text and cor-
responding monetary image) and the cumulative total. The rela-
tionships between baseline block mean RT, SD, and test block 
feedback were as follows:
very fast accurate responses: For very fast accurate responses 
in which RT during a trial in the test blocks was < -0.5 SD of the 
baseline RT, the response was followed by the text “YOU WIN!! 
EXCELLENT!!” along with a £1 image. If subjects won £1 in 3 
sequential trials, the feedback increased to £2.
fast accurate responses: For accurate responses in which test 
RT was between -0.5 SD and +0.5 SD of the baseline RT, the 
response was followed by the text “Very good. Keep going.” along 
with a 50-pence image. Test RTs that were accurate and between 
+0.5 SD and +1.5 SD of the baseline RT were followed by the text 
“Good. Keep going.” along with a 10-pence image.
slow accurate responses: Slow but accurate responses in which 
trial RTs were > +1.5 SD of the baseline RT were penalized and 
followed by the text “YOU LOSE!! TOO LATE!! HURRY UP!!” and an 
image of -£1 with a red X over the coin.
no response: If no responses were registered, the feedback was 
“TOO LATE!! GO FASTER!!” with an image -£1 with a red X.
premature response or incorrect responses: Neither prema-
ture responses (responding prior to target onset) nor incorrect 
responses (touching the incorrect box) were penalized. Follow-
ing a premature response, subjects were required to touch the 
screen to complete the trial, which was followed by the text 
“Keep going.” An incorrect response was followed by the text 
‘Keep going.” Thus, in both these cases, the response is subop-
timal in that the time required for the trial is not rewarded and 
has parallels with a time out in the rodent literature.
Figure 1. Premature responding task and outcomes. 4-Choice Serial Reaction Time task (4-CSRT). Reaction time (RT) was measured as the RT from green target onset to 
release of space bar; Movement time (MT) was measured as the RT from release of the space bar to touching the screen. The graph represents premature responses in 
healthy individuals on methylphenidate (MPH) or placebo. Higher premature responding represents greater impulsivity. Error bars represent between subject standard 
error of the mean. *P < .05
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Test Blocks
There were 4 test blocks with monetary feedback (40 trials/block). 
Subjects were instructed to respond as quickly as possible. They 
were told that they would earn money for their responses and 
would earn more money for faster responses. They were told 
that it was more important to be fast rather than accurate and 
that they would not lose money if they were inaccurate.
In the baseline blocks without feedback, the target duration 
was 64 milliseconds and the cue-target interval was 2 seconds. 
In test block 1 (long target) with monetary feedback, the target 
duration and cue-target interval were the same as the baseline 
blocks. In test block 2 (short target), the target duration was 32 
milliseconds and the cue-target interval was 2 seconds. In test 
block 3 (variable interval), the target duration was 32 milliseconds 
and the cue-target interval varied from 2 to 10 seconds. In test 
block 4 (distractor), red circles followed by yellow circles appeared 
sequentially and randomly in 1 of the 4 boxes during the cue-
target interval (2–10 seconds) prior to onset of the green target 
(target duration 32 milliseconds). The distractor circles were pre-
sented for 32 milliseconds for a random number. The distance 
between the touch screen and keyboard was held constant for 
each individual throughout the course of the experiment.
Primary outcome measures included total premature 
responses, which includes premature release (as reported in 
previous studies) (Voon et al., 2014; Worbe et al., 2014), and pre-
mature responses (touching the cue on the screen prior to tar-
get onset). Other secondary and exploratory outcome measures 
included motivation index ([baseline RT2 – baseline RT1]/base-
line RT 1); RT (RT = time from target onset to space bar release); 
movement time (MT = time from release of the space bar to touch 
screen); accuracy (correct responses/correct responses + incor-
rect responses), where incorrect responses were trials in which 
the participant responded in time but to the wrong box (but were 
not penalized); late responses (during which participants were 
penalized by monetary loss); total won; and proportion of prema-
ture responses following a premature response, monetary win, 
or monetary loss (=premature responses following a premature 
response, monetary win, or monetary loss divided by total pre-
mature response, monetary win, or monetary loss, respectively).
Beads Task
Participants were shown 2 jars on the computer screen with 
opposite ratios of red and blue beads (Jar 1: P = .80 red; P = .20 
blue / Jar 2: P = .80 blue; P = .20 red) (Figure 3). They were informed 
of the bead ratio and were told that beads from 1 of the jars 
would be presented 1 at a time in the center of the screen. The 
participants’ goal was to infer whether the beads were drawn 
from Jar 1 or Jar 2. The participants were free to view as many 
beads as they wanted to a maximum of 20 beads before com-
mitting to their decision. The decision was followed by a con-
fidence rating in which participants used a mouse to indicate 
the degree of confidence that their answer was correct on a line 
anchored at “not confident” to “very confident.” Participants 
were then informed that the next block would start. In this ver-
sion, there was no feedback. The task controlled for working 
memory by showing the colored beads drawn across 2 rows at 
the top of screen. There was no time limit to the task. The pri-
mary outcome measure was the number of beads drawn prior to 
a decision or the amount of evidence accumulated. Secondary 
outcomes included subjective confidence and objective prob-
ability of the correct jar at the time of decision. There were 3 
blocks of trials with the same bead order used in a previous 
study (Moutoussis et al., 2011).
Statistics
All data were inspected for outliers (>3 SD from group mean) 
with outliers removed from analysis. The Kolmogorov-Smirnoff 
test was used to assess normality of distribution and log10 
transformation applied to data that were not normally distrib-
uted. Paired t tests were used to assess data on MPH and pla-
cebo. The number of beads in the beads task was also analyzed 
as a function of baseline impulsivity by dividing groups based 
on a median split of high and low placebo baseline impulsiv-
ity or number of beads to decision (median  =  7.33). The dif-
ference between the number of beads on placebo vs MPH was 
compared between the high and low baseline impulsivity 
groups using independent t tests. P < .05 was considered sig-
nificant. For study 1, the ratio of premature responses follow-
ing the highest positive feedback (+£2), negative feedback (-£1), 
or a premature response relative to total premature responses 
was compared using a paired t test for the comparison of MPH 
and placebo. For study 2, to allow comparisons between all 
the different groups, we combined the healthy controls and 
conducted a mixed-measures ANOVA with within-subject fac-
tor of feedback and between subject factor of group including 
healthy controls and all subject groups. P < .05 was considered 
significant.
Results
In study 1, 28 participants were tested (female = 22; age 20.71 
[1.84 SD] years; verbal IQ 113.41 [4.66 SD]; BDI 9.8 [10.2 SD]; STAI-
state 40.5 [12.5 SD]; UPPS total 154.96 [18 SD]).
In study 2, 30 AUD, 30 obese with BED and 30 without 
BED, 23 Stim, and 32 BD were compared with all combined 
healthy volunteers (N = 84). Primary diagnoses were con-
firmed by a psychiatrist using the DSM IV-TR criteria for 
substance dependence and Research Diagnostic Criteria for 
BED (Association, 2000). Healthy volunteers, AUD, and obese 
with and without BED were excluded if they had a current 
major depression or other major psychiatric disorder, includ-
ing substance addiction (except nicotine), major medical ill-
ness, or taking psychotropic medications. Detailed subject 
characteristics have been previously reported (Voon et  al., 
2014). We have previously reported higher premature release 
scores (Voon et al., 2014). In Table 1, we report both premature 
release and total premature responses (premature response 
and release).
Effects of MPH on Waiting Impulsivity
As the MPH data for total premature responses, RT, MT, pro-
portion of premature responses after a premature response, 
monetary win or monetary loss, accuracy, and late trials were 
not normally distributed, these data were log10 transformed. 
MPH was associated with significantly more total premature 
responses (nontransformed data reported in mean [SD]: pla-
cebo: 7.07 [6.46]; MPH: 10.63 [8.94], t(28) = -2.38, P = .043) with a 
trend for greater premature releases in the MPH compared 
with placebo condition (placebo: 5.96 [5.43]; MPH: 8.41 [7.05]; t(28) 
= -2.15, P = .053).
MPH was associated with faster RT (placebo: 381.91 [105.36] 
msec; MPH: 368.94 [95.85] msec, t(28)= 2.16, P = .040). However, no 
differences were observed for MT (placebo: 274.31 [59.54]; MPH: 
282.70 [87.36], t(28)= -0.46, P = .646) (Figure 2A).
There were no significant differences between MPH and 
placebo in the ratio of premature responses after a premature 
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response (t = -1.25, P = .222), negative feedback (t = 1.29, P = .210), 
or positive feedback (t = 1.30, P = .206) (Table 2).
There were no differences in motivational index (placebo: 
0.22 [0.19]; MPH: 0.22 [0.16], t(28) = 0.03, P = .975), accuracy (placebo: 
0.92 [0.06], MPH: 0.92 [0.06], t(28) = -0.13, P = .897), late responses 
(placebo: 10.41 [11.74]; MPH: 7.81 [4.98], t = 0.53, P = .601) or 
amount won (placebo: 1114.74 [428.83]; MPH: 1066.52 [405.64], 
t(28) = 0.49, P = .627).
The ratio of correct fast (win £2), correct slow (win £1 or 
£0.50), miss, or late (lose £1) responses following a premature 
response, monetary win, or monetary loss were also examined 
to assess specificity of the premature response findings. There 
were no significant differences between MPH and placebo in 
these measures (P > .05).
Effects of MPH on Evidence Accumulation
As the number of beads and confidence were not normally dis-
tributed, the data were log10 transformed. One participant was 
removed from placebo number of beads and confidence and 
MPH confidence, as the data were outliers (>3 SD from group 
mean). MPH was not different from placebo in the number of 
beads to decision (placebo: 7.81 [4.07]; MPH 7.17 [3.37], t = 1.35, 
P = .250). However, when analyzed as a function of baseline 
placebo impulsivity, participants with low baseline impulsiv-
ity (beads > 7.33 at baseline) showed an increase in reflection 
impulsivity on MPH with an opposite (decrease) observed in 
those with high baseline impulsivity (beads < 7.33 at baseline) 
Table 1. Total Premature Responses and Premature Release
Premature 
release (SD)
Total premature 
response (SD)
AUD 10.17 (8.79) 13.85 (10.03)
AUD-HV 6.02 (4.36) 8.03 (5.77)
T 2.317 2.755
P 0.024 0.008
Stim 13.35 (6.77) 18.76 (9.44)
Stim-HV 7.52 (5.59) 9.41 (6.68)
T 3.05 3.695
P 0.004 <0.001
BD 10.86 (7.21) 14.62 (7.74)
BD-HV 7.15 (6.12) 9.64 (8.11)
T 2.149 2.433
P 0.036 0.018
Methylphenidate-HV 8.41 (7.05) 10.63 (8.94)
Placebo-HV 5.96 (5.43) 7.07 (6.46)
2.15 2.38
0.053* 0.043*
*paired t-test.
Abbreviations: AUD, alcohol use disorder; HV, healthy volunteer; Stim, stimu-
lant use disorder; BD, binge drinker.
Figure 2. Secondary outcomes of premature responding task. (A) Reaction time (RT; left: RT = time from target onset to release of space bar) and movement time (right: 
MT = time from release of space bar to touching the screen) in healthy individuals on methylphenidate (MPH) or placebo. (B) Ratio of premature responses following 
monetary loss (left) and prior premature response (right). Error bars represent between subject standard error of the mean. *P < .05, ♮P = .065.
Table 2. Number of Premature Responses following Feedback
Prem  
following 
prem
Prem  
following  
negative  
feedback
Prem  
following 
positive  
feedback
Healthy volunteers 1.96 (3.45) 0.86 (1.34) 4.69 (3.46)
0.13 (0.14) 0.07 (0.12) 0.48 (0.25)
AUD 3.89 (6.77) 1.07 (1.38) 5.93 (5.49)
0.18 (0.18) 0.09 (0.10) 0.51 (0.28)
Stim 5.09 (6.12) 0.76 (1.18) 7.94 (4.87)
0.21 (0.16) 0.04 (0.05) 0.53 (0.24)
BD 3.62 (5.37) 0.86 (1.36) 6.31 (3.61)
0.18 (0.18) 0.06 (0.08) 0.48 (0.20)
BED 0.70 (1.26) 0.55 (0.85) 3.96 (2.61)
0.08 (0.13) 0.06 (0.09) 0.58 (0.29)
Obese 1.19 (2.10) 0.97 (1.20) 4.29 (3.65)
0.10 (0.15) 0.12 (0.15) 0.47 (0.25)
Methylphenidate-HV 3.18 (1.00) 0.62 (0.57) 4.41 (4.25)
0.17 (0.24) 0.04 (0.07) 0.52 (0.25)
Placebo-HV 1.0 (2.12) 0.57 (1.12) 4.25 (3.32)
0.10 (0.14) 0.08 (0.14) 0.61 (0.24)
Reported as actual number of premature responses per category (mean (SD) 
and ratio per category relative to total premature responses (mean (SD).
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(difference MPH – placebo in number of beads: high baseline 
impulsivity: 1.25 [2.04]; low baseline impulsivity: -2.55 [2.61], 
t = 4.14, P < .001) (Figure 3). Similarly, baseline placebo impulsivity 
(number of beads) was negatively correlated with the difference 
between the number of beads on placebo and on MPH (Pearson 
correlation coefficient: R2 = 0.28, P = .003).
There were no differences between MPH and placebo on sec-
ondary outcome measures of subjective confidence (placebo: 
438.40 [65.26]; MPH: 456.76 [62.89], t = -1.67, P = .108), objective 
probability, or levels of uncertainty at the time of decision (pla-
cebo: 0.91 [0.17]; MPH: 0.94 [0.12], P = .273).
There was no relationship between premature responses and 
number of beads or confidence under MPH or placebo (P > .05). 
The total premature responses at baseline were divided into 
high (9.25 [SD 9.74] and low 2.75 [SD 1.14]) and the influence of 
MPH (high impulsive: 12.83 [SD 9.34]; low impulsive: 12.08 [7.20]) 
assessed using mixed-measures ANOVA. There was a group 
effect (P = .021), a trend towards a medication effect (P = .052), and 
no interaction between group and medication (P = .117). A simi-
lar analysis of premature releases showed a group effect (P = .002) 
but no medication (P = .143) or interaction (P = .613) effect.
The relationship between the 2 forms of impulsivity was further 
investigated. First, we divided it into high and low impulsivity based 
on a median split from the beads task. We then assessed the rela-
tionship between total premature responses on placebo in those 
with high reflection impulsivity (total premature responses: 10.00 
[SD 8.97]) and low reflection impulsivity (5.50 [SD 3.58]) (P = .123) on 
placebo. Although the difference was not significant, notably given 
the differences between the raw scores, this might suggest a poten-
tial relationship between the 2 measures given a sufficient sample 
size. Similarly, we investigated the correlation between total prema-
ture responses and premature responding (placebo: Pearson corre-
lation: r = 0.281; P = .156; MPH: r = -0.106; P = .590)
Premature Responses following Feedback in 
Disorders of Addiction
There was a main effect of feedback (F(2,222) = 210.78, P < .001) 
and a group by feedback interaction (F(10,446) = 2.63, P = 0.004) 
and no group effect (F(5,223) = 1.12, P = .353). To further under-
stand the interaction effects, we conducted posthoc analyses 
using Tukey test. There were significant group differences fol-
lowing a premature response (P = .008) and negative feedback 
(P = .046) but not following positive feedback (P = .439). Stim 
subjects made more premature responses following a prema-
ture response compared with healthy volunteers (P = .019), BED 
(P = .001), and obese without BED (P = .005). BED subjects made 
fewer premature responses following a premature response 
compared with BD (P = .019) and AUD subjects (P = .027). Obese 
subjects made more premature responses following negative 
feedback compared with healthy volunteers (P = .048), Stim 
(P = .002), BED (P = .019), and BD subjects (P = .023).
Discussion
Here we show a dissociation of the effects of MPH on 2 subtypes 
of impulsivity. Specifically, MPH enhanced waiting impulsivity 
or premature responding prior to a cue predicting reward across 
participants in healthy volunteers. In contrast, MPH influences 
on reflection impulsivity were dependent on baseline reflection 
impulsivity, with low baseline impulsivity participants showing 
an increase and high baseline participants a decrease in reflec-
tion impulsivity.
On MPH, participants responded earlier to the target onset 
(ie, faster relative RT from target onset to space bar release) 
without a generalized speeding of RT (ie, RT from space bar 
release to touching the screen) or attention (ie, accuracy or 
missed responses). Thus, MPH may enhance task-specific atten-
tional salience (ie, to the target predicting reward). In partici-
pants with low baseline reflection impulsivity, MPH enhanced 
impulsivity with an opposing effect in participants with high 
baseline reflection impulsivity.
Feedback Effects
We have previously shown that premature responding is ele-
vated in Stim, AUD, and BD subjects but not in obese subjects 
with and without BED (Voon et al., 2014). Here we show group 
Figure 3. Reflection impulsivity task. Beads task. The graph represents the number of beads or evidence accumulated in healthy individuals on methylphenidate (MPH) 
or placebo as a function of high or low reflection impulsivity at baseline on placebo. Lower number of beads represents greater impulsivity. Error bars represent between 
subject standard error of the mean. *P < .001
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by feedback interaction differences in premature responding, 
particularly following a premature response and negative feed-
back (Figure 4). The influence of premature response was driven 
particularly by Stim subjects and BED: Stim subjects made more 
premature responses following a premature response compared 
with healthy volunteers and with both obese subjects with and 
without BED, whereas BED subjects made fewer premature 
responses following a premature response compared with BD 
and AUD subjects. These findings in Stim subjects of a repeat 
of premature response following a premature response suggest 
impaired learning from a prior premature response and an aber-
rant recognition that premature responses are suboptimal. This 
might suggest that the lack of a reward or the brief time delay 
following a premature response is insufficiently salient in Stim 
subjects.
Obese subjects made more premature responses following 
negative feedback compared with healthy volunteers, Stim, 
BED, and BD subjects, suggesting possibly enhanced frustrative 
motivation responding. These findings might suggest a role for 
enhanced sensitivity to negative feedback (Wise and Koob, 2014).
Acute MPH Effects on Premature Responding
MPH acts by inhibiting dopamine and noradrenergic transport-
ers and has been shown to increase presynaptic striatal dopa-
mine (Volkow et  al., 2001a) and striatal dopamine synthesis 
capacity (Henkel, 1981) as well as increasing synaptic levels of 
noradrenaline through its blockade of noradrenergic transport-
ers (Hannestad et al., 2010) in humans. In rodents, MPH increases 
premature responding, an effect blocked by the beta-adrenergic 
receptor blocker propranolol and a D4 receptor antagonist but 
not by central noradrenergic depletion or D1 or D2 receptor 
antagonists (Milstein et al., 2010). These findings suggest that the 
influence of MPH on premature responding acts specifically via 
the beta-adrenergic receptor and D4 receptor. Infusion of MPH 
into the nucleus accumbens core but not the shell enhances 
premature responding, whereas infusion of atomoxetine, a 
specific noradrenergic reuptake inhibitor, into the nucleus 
accumbens shell but not the core decreases premature respond-
ing (Economidou et al., 2012). This indicates neurochemical and 
anatomical dissociability in the nucleus accumbens on prema-
ture responding. The influence of MPH on premature responding 
may also be related to dose as MPH improves attention (percent 
correct) in the 5CSRT across multiple doses, but only the high-
est dose of MPH increased premature responding (Navarra et al., 
2008). Atomoxetine consistently decreased premature respond-
ing and, less consistently, improved attention in rodents on both 
the 5-CSRT (Robinson et al., 2008; Baarendse and Vanderschuren, 
2012; Fernando et al., 2012; Paterson et al., 2012) and in a rodent 
gambling task (Baarendse et al., 2013). Thus, our finding of ele-
vated premature responses following MPH in healthy adults 
converges with the rodent literature whereas atomoxetine may 
be more likely to decrease premature behavior.
In healthy humans, MPH improves motor inhibition as 
measured by stop signal task performance, possibly by enhanc-
ing salience of the stop signal and increasing attentional cap-
ture (Nandam et al., 2011; Pauls et al., 2012; Costa et al., 2013; 
Farr et al., 2014). Similarly, the influence of MPH on premature 
responding in this study may be related to enhanced salience 
of the target, hence hastening RT to the target or enhanced sali-
ence of negative feedback and therefore increasing premature 
responses following negative feedback. Importantly, we show 
enhanced RT to the target but no overall effect on RT, suggesting 
a specific mechanism involving the target or negative feedback. 
In an fMRI study of MPH in healthy volunteers using a 4-CSRT 
task that did not focus on premature responding, MPH was 
associated with enhanced activity in attention and preparatory 
motor regions (Muller et al., 2005). An influence of task-difficulty 
and plasma levels was observed with a positive correlation 
between greater area under the plasma MPH-time curve and 
activity of attentional and motor preparatory regions only in the 
condition of greater task difficulty (Muller et al., 2005). In healthy 
volunteers, MPH increases activity in a dorsal attentional net-
work, including the parietal and prefrontal cortex (Tomasi et al., 
Figure 4. Premature response following feedback. (A) Ratio of premature responses following a premature response comparing healthy volunteers (HV), subjects 
abstinent from methamphetamine dependence (Stim) and alcohol use disorders (AUDs) and in binge drinkers (BDs) and obese subjects with and without binge eating 
disorder (BED). Ratio of premature responses following monetary loss (B) and following a monetary win (C).
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2011). Overall these findings suggest the influence of MPH on 
premature responding may relate to enhanced task-dependent 
attentional salience and motor preparation.
Acute MPH in healthy volunteers appears to have multiple 
influences on enhancing cognition, including enhancing set 
shifting and memory consolidation (Linssen et al., 2012) as well 
as working memory and planning. Improvements in working 
memory were related to decreases in cerebral blood flow in lat-
eral prefrontal and parietal cortices (Elliott et  al., 1997; Mehta 
et  al., 2000b) and also to baseline-dependent effects (Mehta 
et al., 2000a, 2004). However, not all effects are necessarily posi-
tive. MPH increases risk-taking behavior in healthy individuals 
(Campbell-Meiklejohn et al., 2012). In the current study, we show 
that acute MPH increases premature responding along with 
causing an enhanced likelihood of a premature response fol-
lowing a prior premature response. This suggests that MPH may 
also impair the capacity to learn that premature responses are 
suboptimal responses, possibly by a relative decrease in atten-
tional salience. However, we also note that there were no overall 
differences in the amount of money won, suggesting that MPH 
did not impair optimal task performance.
Acute MPH Effects on Evidence Accumulation
We also show that MPH influences evidence accumulation prior 
to a decision in a manner that is dependent on baseline impul-
sivity. These divergent effects of MPH were previously demon-
strated for other forms of impulsivity. For example, MPH and 
atomoxetine were both shown to decrease premature responding 
in high-impulsive rodents in one study (Tomlinson et al., 2014). 
MPH also enhances motor inhibition as measured using the stop 
signal task, reducing the stop signal reaction time (SSRT) in slow-
responding rodents but increasing SSRT in fast responders (Eagle 
et al., 2007). In humans, individuals with higher baseline impul-
sivity such as those with attention deficit hyperactivity disorder 
may respond differently to MPH (Caprioli et  al., 2015). Overall, 
this suggests an influence of baseline on medication effects, thus 
emphasizing potential differences between medication effects 
in healthy volunteers and pathological groups with elevated 
impulsivity. In the current study, there were no differences in 
levels of uncertainty or objective probability of the correct choice 
at the time of decision or in subjective confidence, suggesting 
that the effects were indeed related to reflection impulsivity. 
In line with the current finding of reduced reflection impulsiv-
ity in high-impulsive participants, greater reflection impulsivity 
as tested using the Matching Familiar Figures Test in individuals 
with attention deficit hyperactivity disorder is decreased follow-
ing MPH (Brown and Sleator, 1979). However, there were no dif-
ferences in reflection impulsivity comparing ADHD and healthy 
volunteers as measured using the Information Sampling Task 
along with a lack of an influence of MPH (DeVito et  al., 2009). 
We have previously shown that BDs were impaired on the beads 
task but not the IST (Banca et al., 2015), a dissociation similarly 
shown in studies in schizophrenia (Fine et al., 2007; Moutoussis 
et al., 2011) (Huddy et al., 2013) suggesting underlying task differ-
ences. We argue that the beads task, unlike the IST, may be more 
likely to increase impulsivity, as the task is less visually explicit 
and requires participants to be reliant on their own internal task 
representation and future outcomes (Banca et al., 2015).
Limitations
This current study would benefit from assessment under differing 
doses at 20 and 40 mg to assess dose effects. Furthermore, whereas 
MPH appears to improve motor response inhibition in healthy 
volunteers with a possible enhanced effect in ADHD, the role of 
premature responding in ADHD and the influence of chronic MPH 
remains to be tested. We also note that baseline scores of premature 
responding may subtly differ, possibly as a result of differences in 
the touch screen utilized. In the study of pathological groups (study 
2), a larger 12.1-inch Paceblade touchscreen was used, whereas a 
10.1-inch touch screen was used in Study 1, which may contribute 
to differences in baseline responses. We further note that subjects 
with lower beads accumulated (greater reflection impulsivity) had 
higher raw scores of total premature responses (greater waiting 
impulsivity) with the opposite observed in those with lower reflec-
tion impulsivity. Although there were no significant differences 
either with a correlation analysis or a median split, a larger sam-
ple size might reveal a relationship between the 2 measures. Thus, 
those who accumulate less evidence may also have difficulties 
with anticipatory responding.
Conclusions
Our findings are immediately relevant to young healthy volun-
teers without a history of ADHD. While acute MPH may have 
positive effects as a cognitive enhancer in healthy volunteers, 
MPH may also enhance specific forms of impulsivity, includ-
ing the capacity to wait before acting. Our findings suggest that 
chronic exposure to stimulants is associated with a failure to 
learn that premature responses are suboptimal. These findings 
add to a mechanistic understanding of waiting impulsivity and 
possible means of therapeutic interventions.
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